282 related articles for article (PubMed ID: 15515284)
1. Managing breakthrough pain: a clinical review with three case studies using oral transmucosal fentanyl citrate.
Rhiner M; Palos G; Termini M
Clin J Oncol Nurs; 2004 Oct; 8(5):507-12. PubMed ID: 15515284
[TBL] [Abstract][Full Text] [Related]
2. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
3. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies.
Davies A; Zeppetella G; Andersen S; Damkier A; Vejlgaard T; Nauck F; Radbruch L; Sjolund KF; Stenberg M; Buchanan A
Eur J Pain; 2011 Aug; 15(7):756-63. PubMed ID: 21251860
[TBL] [Abstract][Full Text] [Related]
4. Managing breakthrough cancer pain: a new approach.
Rhiner M; Kedziera P
Home Healthc Nurse; 1999 Jun; 17(6 Suppl):suppl 1-12; quiz 13-5. PubMed ID: 10562023
[TBL] [Abstract][Full Text] [Related]
5. Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management.
Fine PG; Narayana A; Passik SD
Pain Med; 2010 Jul; 11(7):1024-36. PubMed ID: 20642730
[TBL] [Abstract][Full Text] [Related]
6. The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen.
Mercadante S; Villari P; Ferrera P; Mangione S; Casuccio A
Clin J Pain; 2010 May; 26(4):306-9. PubMed ID: 20393265
[TBL] [Abstract][Full Text] [Related]
7. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.
Mystakidou K; Katsouda E; Parpa E; Tsiatas ML; Vlahos L
Am J Hosp Palliat Care; 2005; 22(3):228-32. PubMed ID: 15909786
[TBL] [Abstract][Full Text] [Related]
8. Impact and management of breakthrough pain in cancer.
Zeppetella G
Curr Opin Support Palliat Care; 2009 Mar; 3(1):1-6. PubMed ID: 19365156
[TBL] [Abstract][Full Text] [Related]
9. Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough pain.
Zeppetella G; Messina J; Xie F; Slatkin NE
Pain Pract; 2010; 10(4):287-93. PubMed ID: 20230447
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; OroĊska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
11. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262
[TBL] [Abstract][Full Text] [Related]
12. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
[TBL] [Abstract][Full Text] [Related]
13. Fentanyl buccal tablet: faster rescue analgesia for breakthrough pain?
Lecybyl R; Hanna M
Future Oncol; 2007 Aug; 3(4):375-9. PubMed ID: 17661711
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
Portenoy RK; Taylor D; Messina J; Tremmel L
Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
[TBL] [Abstract][Full Text] [Related]
15. The role of oral transmucosal fetanyl citrate in the management of breakthrough cancer pain.
Rees E
Int J Palliat Nurs; 2002 Jun; 8(6):304-8. PubMed ID: 12131825
[TBL] [Abstract][Full Text] [Related]
16. Oral transmucosal fentanyl citrate for cancer breakthrough pain: a review.
Gordon DB
Oncol Nurs Forum; 2006 Nov; 33(2):257-64. PubMed ID: 16518441
[TBL] [Abstract][Full Text] [Related]
17. The rationale for a multimodal approach in the management of breakthrough cancer pain: a review.
Soares LG; Chan VW
Am J Hosp Palliat Care; 2007; 24(5):430-9. PubMed ID: 17582029
[TBL] [Abstract][Full Text] [Related]
18. Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.
Zeppetella G
J Pain Symptom Manage; 2008 May; 35(5):563-7. PubMed ID: 18258412
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough pain in cancer patients.
Zeppetella G
Clin Oncol (R Coll Radiol); 2011 Aug; 23(6):393-8. PubMed ID: 21227666
[TBL] [Abstract][Full Text] [Related]
20. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
Slatkin NE; Xie F; Messina J; Segal TJ
J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
